APA (7th ed.) Citation

SC, L., OX, M., AA, A., D, R., J, B., DJ, M., . . . MA, B. (2026). Immune shielding of viral vectors via capsid engineering with genetically encoded zwitterionic peptides. Molecular therapy. Advances, 34(1), 201694. https://doi.org/10.1016/j.omta.2026.201694

Chicago Style (17th ed.) Citation

SC, Lu, et al. "Immune Shielding of Viral Vectors via Capsid Engineering with Genetically Encoded Zwitterionic Peptides." Molecular Therapy. Advances 34, no. 1 (2026): 201694. https://doi.org/10.1016/j.omta.2026.201694.

MLA (9th ed.) Citation

SC, Lu, et al. "Immune Shielding of Viral Vectors via Capsid Engineering with Genetically Encoded Zwitterionic Peptides." Molecular Therapy. Advances, vol. 34, no. 1, 2026, p. 201694, https://doi.org/10.1016/j.omta.2026.201694.